-
1دورية أكاديمية
المؤلفون: Camisaschi, C, Filipazzi, P, Tazzari, M, Casati, C, Beretta, V, Pilla, L, Patuzzo, R, Maurichi, A, Cova, A, Maio, M, Chiarion Sileni, V, Tragni, G, Santinami, M, BERTI, EMILIO, Umansky, L, Beckhove, P, Umansky, V, Parmiani, G, Rivoltini, L, Castelli, C., VERGANI, BARBARA, VILLA, ANTONELLO
المساهمون: Camisaschi, C, Filipazzi, P, Tazzari, M, Casati, C, Beretta, V, Pilla, L, Patuzzo, R, Maurichi, A, Cova, A, Maio, M, Chiarion Sileni, V, Tragni, G, Santinami, M, Vergani, B, Villa, A, Berti, E, Umansky, L, Beckhove, P, Umansky, V, Parmiani, G, Rivoltini, L, Castelli, C
مصطلحات موضوعية: Cyclophosphamide, Immunotherapy, Melanoma, Regulatory T cell, Adult, Aged, Antigens, Neoplasm, Antineoplastic Agents, Alkylating, CD4-Positive T-Lymphocyte, CD8-Positive T-Lymphocyte, Cell Line, Tumor, Enzyme-Linked Immunosorbent Assay, Female, Flow Cytometry, Histocompatibility Antigens Class I, Human, Immunosuppressive Agent, Interferon-gamma, Interleukin-2, Leukocytes, Mononuclear, Male, Middle Aged, Phenotype, Skin Neoplasm, T-Lymphocyte, Time Factor
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23589107; info:eu-repo/semantics/altIdentifier/wos/WOS:000318299700007; volume:62; issue:5; firstpage:897; lastpage:908; numberofpages:12; journal:CANCER IMMUNOLOGY, IMMUNOTHERAPY; http://hdl.handle.net/10281/72937Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84877814153
-
2
المؤلفون: Antonello Villa, Ludmila Umansky, Chiara Camisaschi, Michele Maio, Philipp Beckhove, Giorgio Parmiani, Gabrina Tragni, Barbara Vergani, Vanna Chiarion-Sileni, Marcella Tazzari, Agata Cova, Chiara Castelli, Valeria Beretta, Emilio Berti, Paola Filipazzi, Lorenzo Pilla, Viktor Umansky, Licia Rivoltini, Roberto Patuzzo, Andrea Maurichi, Chiara Casati, Mario Santinami
المساهمون: Camisaschi, C, Filipazzi, P, Tazzari, M, Casati, C, Beretta, V, Pilla, L, Patuzzo, R, Maurichi, A, Cova, A, Maio, M, Chiarion Sileni, V, Tragni, G, Santinami, M, Vergani, B, Villa, A, Berti, E, Umansky, L, Beckhove, P, Umansky, V, Parmiani, G, Rivoltini, L, Castelli, C
المصدر: Cancer Immunology, Immunotherapy
مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Male, Cancer Research, Skin Neoplasms, Time Factors, T-Lymphocytes, medicine.medical_treatment, CD8-Positive T-Lymphocytes, Immunosuppressive Agent, Immunology and Allergy, Lymph node, Melanoma, ELISPOT, hemic and immune systems, Regulatory T cells, Middle Aged, Flow Cytometry, Vaccination, Phenotype, medicine.anatomical_structure, Oncology, CD4-Positive T-Lymphocyte, Original Article, Female, Immunotherapy, Immunosuppressive Agents, Human, medicine.drug, Adult, Interleukin 2, Time Factor, T cell, Immunology, Enzyme-Linked Immunosorbent Assay, Cyclophosphamide, Immunotherapy, Melanoma, Regulatory T cells, Interferon-gamma, Antigen, Antigens, Neoplasm, Cell Line, Tumor, medicine, Humans, Skin Neoplasm, Antineoplastic Agents, Alkylating, Cyclophosphamide, Aged, business.industry, Histocompatibility Antigens Class I, CD8-Positive T-Lymphocyte, T-Lymphocyte, Leukocytes, Mononuclear, Interleukin-2, business, Regulatory T cell, CD8
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd8755e90a58520f4aa423574fae9b0Test
http://hdl.handle.net/11365/1081470Test